Eris Biotech

Eris Biotech is dedicated to pioneering a new generation of cancer therapeutics. We are leveraging small molecule inhibitors to counteract immune suppression within the tumor microenvironment. Our innovative drugs are designed to activate and direct the immune system to aggressively target and eliminate tumors. Initially, our therapeutic pipeline is focused on addressing a spectrum of solid tumors, with a primary emphasis on developing effective treatments for mesothelioma.